Drugs / Multivalent
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02955160 | Nov 2016 → Aug 2017 | pneumococcal infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Multivalent | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02955160 ↗ |
| Modality | Vaccine | “multivalent pneumococcal conjugate vaccine” NCT02955160 ↗ |
| Route | Intramuscular | “single intramuscular dose of multivalent pneumococcal conjugate vaccine” NCT02955160 ↗ |